title: Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
abstract: Liver cancer is one of the most frequent and lethal malignancies worldwide. Early detection is hampered by the absence of reliable markers. Mice transgenic for the SV40 large T antigen under the control of a liver-specific promoter spontaneously develop well-differentiated hepatocellular carcinomas between 8 to 10 weeks of age. They are excellent models to investigate the alterations of protein expression in the early stages of tumor development and to follow these changes during tumor progression. In the present study, we analyzed the glycosylation changes occurring during tumor development in transgenic mice expressing the SV40 T antigen under the control of the antithrombin III promoter. The analysis of serum and liver glycoproteins by an ELISA type assay, using the lectin from Sambucus nigra (SNA) as a probe, revealed the presence of increased levels of Neu5Ac alpha2,6Gal beta1,4GlcNAc on N-glycans in the tumor-bearing transgenic mice as compared to controls. On serum glycoproteins the increase in alpha2,6 sialylation followed tumor progression, reaching up to 10 times control levels. However, significantly higher SNA binding (2-fold) could already be observed on serum glycoproteins from mice exhibiting only microscopically small neoplastic foci. On liver membrane glycoproteins, the increase in alpha2,6 sialylation was less pronounced, reaching two to three times control values in 6-month-old mice. Western blotting of serum and liver proteins with radiolabeled SNA showed that all glycoproteins that bind the lectin in controls exhibit larger amounts of Neu5Ac alpha2,6Gal beta1,4GlcNAc on N-glycans in the tumor-bearing mice. This general increase in alpha2,6 sialylation on all glycoproteins is due to the increased activity of the galactoside:alpha2,6 sialyltransferase (ST6Gal I), which specifically transfers Neu5Ac residues in alpha2,6 linkage to Gal beta1,4GlcNAc units on N-glycans. As for the structures synthesized by the enzyme, the increase of ST6Gal I activity in the serum as well as in liver microsomes of the transgenic mice followed tumor progression. Interestingly, the activity of the galactoside:alpha2,3 sialyltransferase (ST3Gal III), which uses the same acceptor substrate (Gal beta1,4GlcNAc), was unchanged in the earlier stages of tumor development but decreased in the serum and in liver microsomes from later stages. Using a rat ST6Gal I cDNA as a probe, Northern blots of total RNA extracted from the livers of control and transgenic mice revealed an increased (4-fold) expression of the ST6Gal I gene. The single transcripts detected in both normal and cancerous liver showed identical size.
authors.affiliation: Glycobiologie, Centre de Biophysique Moléculaire, Orléans, France.
authors.forename: D
authors.initials: D
authors.lastname: Pousset
authors.forename: V
authors.initials: V
authors.lastname: Piller
authors.forename: N
authors.initials: N
authors.lastname: Bureaud
authors.forename: M
authors.initials: M
authors.lastname: Monsigny
authors.forename: F
authors.initials: F
authors.lastname: Piller
mesh_terms: D000818:Animals; D000957:Antigens, Viral, Tumor / Q000502:physiology; D001798:Blood Proteins / Q000378:metabolism; D002240:Carbohydrate Sequence; D018450:Disease Progression; D004790:Enzyme Induction; D004797:Enzyme-Linked Immunosorbent Assay; D015972:Gene Expression Regulation, Neoplastic; D006023:Glycoproteins / Q000378:metabolism; D006031:Glycosylation; D037102:Lectins / Q000378:metabolism; D008114:Liver Neoplasms, Experimental / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D008862:Microsomes, Liver / Q000378:metabolism; D008969:Molecular Sequence Data; D019158:N-Acetylneuraminic Acid / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000378:metabolism; D037121:Plant Lectins; D011134:Polysaccharides / Q000378:metabolism*; D011499:Protein Processing, Post-Translational; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D012334:RNA, Neoplasm / Q000032:analysis / Q000235:genetics; D051381:Rats; D054788:Ribosome Inactivating Proteins; D012799:Sialyltransferases / Q000235:genetics / Q000378:metabolism*; D013539:Simian virus 40 / Q000235:genetics
chemical_list: D000957:Antigens, Viral, Tumor; D001798:Blood Proteins; D006023:Glycoproteins; D037102:Lectins; D009363:Neoplasm Proteins; D037121:Plant Lectins; D011134:Polysaccharides; D012333:RNA, Messenger; D012334:RNA, Neoplasm; C050600:Sambucus nigra lectins; C098871:Neu5Ac N-acetylgalactosamine 2,6-sialyltransferase; D012799:Sialyltransferases; C038525:CMP-N-acetylneuraminate-alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase; D054788:Ribosome Inactivating Proteins; D019158:N-Acetylneuraminic Acid